Vetoquinol SA (EPA:VETO)
72.40
-0.60 (-0.82%)
Aug 3, 2026, 1:15 PM CET
Vetoquinol Balance Sheet
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Assets
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 221.08 | 206.33 | 147.46 | 93.71 | 69 |
Cash & Short-Term Investments | 221.08 | 206.33 | 147.46 | 93.71 | 69 |
Cash Growth | 7.15% | 39.92% | 57.37% | 35.81% | -46.70% |
Accounts Receivable | 99.02 | 94.83 | 99.22 | 85.35 | 87.2 |
Other Receivables | 10.73 | 3.13 | 8.51 | 7.49 | 1.46 |
Total Trade Receivables | 109.75 | 97.95 | 107.73 | 92.84 | 88.66 |
Inventory | 122.01 | 112.29 | 103.54 | 116.09 | 111.59 |
Other Current Assets | 5.15 | 4.61 | 4.66 | 7.6 | 5.9 |
Total Current Assets | 457.98 | 421.18 | 363.39 | 308.61 | 273.69 |
Net Property, Plant & Equipment | 94.58 | 92.6 | 89.7 | 84.65 | 72.99 |
Other Intangible Assets | 129.67 | 142.09 | 154 | 168.71 | 178.52 |
Goodwill | 70.93 | 76.41 | 75.04 | 76.17 | 83.46 |
Long-Term Investments | 1.45 | 1.52 | 1.49 | 1.44 | 2.07 |
Other Long-Term Assets | 9.02 | 10.33 | 8.62 | 10.63 | 12.38 |
Total Assets | 763.63 | 744.13 | 692.23 | 651.85 | 624.56 |
Liabilities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 134.75 | 128.37 | 125.98 | 125.87 | 140.78 |
Short-Term Debt | 1.64 | 4.39 | 2.99 | 3.3 | 3.92 |
Current Portion of Leases | 5.29 | 5.52 | 4.98 | 4.56 | 4.39 |
Other Current Liabilities | 6.99 | 3.25 | 5.44 | 6.95 | 7.94 |
Total Current Liabilities | 148.67 | 141.53 | 139.39 | 140.39 | 156.77 |
Long-Term Debt | 0.16 | 0.18 | 0.17 | 0.18 | 0.19 |
Long-Term Leases | 8.2 | 11.04 | 9.49 | 9.38 | 6.88 |
Other Long-Term Liabilities | 15.16 | 15.46 | 16.07 | 16.95 | 19.11 |
Total Long-Term Liabilities | 23.52 | 26.67 | 25.73 | 26.51 | 26.18 |
Total Liabilities | 172.19 | 168.2 | 165.12 | 166.89 | 182.95 |
Shareholders' Equity
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 70.83 | 70.83 | 70.83 | 70.83 | 70.83 |
Retained Earnings | 520.54 | 505.01 | 456.18 | 413.74 | 370.43 |
Total Common Shareholders' Equity | 591.37 | 575.84 | 527.01 | 484.57 | 441.26 |
Minority Interest | 0.07 | 0.09 | 0.1 | 0.09 | 0.09 |
Shareholders' Equity | 591.44 | 575.93 | 527.11 | 484.66 | 441.35 |
Total Liabilities & Equity | 763.63 | 744.13 | 692.23 | 651.85 | 624.56 |
Additional Metrics
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 15.29 | 21.12 | 17.63 | 17.42 | 15.38 |
Net Cash (Debt) | 205.78 | 185.21 | 129.84 | 76.29 | 53.62 |
Net Cash Growth | 11.11% | 42.65% | 70.19% | 42.28% | 1069.38% |
Net Cash Per Share | 17.71 | 15.70 | 10.97 | 6.45 | 4.53 |
Book Value | 591.37 | 575.84 | 527.01 | 484.57 | 441.26 |
Book Value Per Share | 50.88 | 48.82 | 44.54 | 40.96 | 37.29 |
Tangible Book Value | 390.78 | 357.34 | 297.98 | 239.69 | 179.28 |
Tangible Book Value Per Share | 33.62 | 30.29 | 25.18 | 20.26 | 15.15 |